Cargando…
Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
Autores principales: | Mera-Cordero, Francisco, Bonet-Monne, Sara, Almeda-Ortega, Jesús, García-Sangenís, Ana, Cunillera-Puèrtolas, Oriol, Contreras-Martos, Sara, Alvarez-Muñoz, Gemma, Monfà, Ramon, Balanzó-Joué, Marina, Morros, Rosa, Salvador-Gonzalez, Betlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827194/ https://www.ncbi.nlm.nih.gov/pubmed/35139906 http://dx.doi.org/10.1186/s13063-022-06073-7 |
Ejemplares similares
-
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
por: Mera-Cordero, Francisco, et al.
Publicado: (2022) -
Evaluating the controlled reopening of nightlife during the COVID-19 pandemic: a matched cohort study in Sitges, Spain, in May 2021 (Reobrim Sitges)
por: Cunillera Puértolas, Oriol, et al.
Publicado: (2022) -
Lasciate ogni speranza voi che entrate
Publicado: (1870) -
Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES)
por: Cunillera-Puértolas, Oriol, et al.
Publicado: (2022) -
Enfermedad renal crónica en Atención Primaria: prevalencia y factores de riesgo asociados
por: Salvador González, Betlem, et al.
Publicado: (2015)